Old Web
English
Sign In
Acemap
>
authorDetail
>
Lingling Wu
Lingling Wu
Schering-Plough
Cancer research
Medicine
Interleukin 23
Inflammation
Antibody
4
Papers
860
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SCH 727965, a novel cyclin-dependent kinase inhibitor, has potent anti-tumor acitivity in a wide-spectrum of human tumor xenograft models
2008
Cancer Research
Yaolin Wang
Xiaoying Wang
Lipari Philip
Bo Yaremko
Ming Liu
Lingling Wu
Martin Oft
Satya Medicherla
David Parry
Emma Lees
Dan Hicklin
Paul Kirschmeier
Show All
Source
Cite
Save
Citations (1)
Pegylated IL-10 for use in the treatment of lymphoma
2007
Martin Oft
Catherine Sheppard
John B. Mumm
Lingling Wu
Show All
Source
Cite
Save
Citations (0)
Langowski JL, Zhang XQ, Wu LL et al.IL-23 promotes tumour incidence and growth. Nature 442:461-465
2006
John L. Langowski
Xueqing Zhang
Lingling Wu
Jeanine D. Mattson
Taiying Chen
Kathy Smith
Beth Basham
Terrill K. Mcclanahan
Robert A. Kastelein
Martin Oft
Show All
Source
Cite
Save
Citations (57)
IL-23 promotes tumour incidence and growth
2006
Nature
John L. Langowski
Xueqing Zhang
Lingling Wu
Jeanine D. Mattson
Taiying Chen
Kathy Smith
Beth Basham
Terrill K. McClanahan
Robert A. Kastelein
Martin Oft
Show All
Source
Cite
Save
Citations (802)
1